GETI-B:STO
Getinge publ AB
SEKÂ 281,60
arrow_upward
+0,57%(+1,60) 1D
13 Nov., 17:29:52 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GETI-B...
Open
SEKÂ 280,20
High
SEKÂ 281,70
Low
SEKÂ 278,70
Mkt. cap
71,57Â mjd
Avg. vol.
535,48Â k
Volume
327,78Â k
Dividend
1,69%
Quarterly dividend
SEKÂ 1,19
Ex-dividend date
22 Apr. 2026
P/E ratio
27,13
52-wk high
SEKÂ 283,00
52-wk low
SEKÂ 175,90
EPS
SEKÂ 10,38
Shares outstanding
254,15Â m
No. of employees
12Â k
Open
SEKÂ 280,20
High
SEKÂ 281,70
Low
SEKÂ 278,70
Mkt. cap
71,57Â mjd
Avg. vol.
535,48Â k
Volume
327,78Â k
Dividend
1,69%
Quarterly dividend
SEKÂ 1,19
Ex-dividend date
22 Apr. 2026
P/E ratio
27,13
52-wk high
SEKÂ 283,00
52-wk low
SEKÂ 175,90
EPS
SEKÂ 10,38
Shares outstanding
254,15Â m
No. of employees
12Â k
News stories
From web sources and news partners
Cision News
·
1 dag gelede
Getinge establishes Sustainable Financing Framework
Profile
Getinge AB is a publicly traded Swedish medical technology company. The company produces and distributes medical products and equipment for the healthcare and life sciences industries. The company is divided into three business areas: Life Science, Acute Care Therapies, and Surgical Workflows. The group employs approximately 12,000 people worldwide. The CEO of the company is Mattias Perjos, and the chairman of the board is Johan Malmquist. With a sales share of around 40%, the United States is by far the most important market for the company due to significantly higher prices and margins there. China and various Western European countries follow. Wikipedia
About Getinge publ AB
CEOMattias Perjos
Employees11,8Â k
Founded1904
Headquarters-
SectorHealth Care
IndustryMedical device
Websitegetinge.com